Dosing Delay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dosing Delay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dosing Delay Today - Breaking & Trending Today

Moleculin Concludes Phase 1b and Opens Recruitment in Phase 2 Clinical Trial of Annamycin for the Treatment of Soft Tissue Sarcoma Lung Metastases

Published: July 28, 2022

/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...

Source: prnewswire.com

Related Topics:

United StatesJenene ThomasWalter KlempExchange CommissionMoleculin Biotech IncDrug AdministrationSecurities ExchangeEastern Cooperative Oncology GroupPreliminary PhaseFast Track StatusOrphan Drug DesignationRecommended PhaseMoleculin ChairmanDosing DelayMoleculin BiotechTranscription ModulatorSecurities ActSecurities Exchange ActPrivate Securities Litigation Reform Act